Interleukin-6 and megakaryocytopoiesis: An update

Annals of Hematology

Volumn 73, Issue 4, 1996, Pages 157-162

  Baatout, S ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

Author keywords

Anemia; Interleukin 6; Megakaryocyte; Platelet function; Thrombocytosis

Indexed keywords

INTERLEUKIN 6;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; B LYMPHOCYTE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LIVER CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPOIESIS;

ANEMIA; ANIMALS; BLOOD PLATELETS; CELLS, CULTURED; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MEGAKARYOCYTES; THROMBOCYTOSIS;

EID: 0029796773     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050220     Document Type: Review

References (90)

1. Akira S, Taga T, Kishimoto T (1993) Interleukin-6 in biology and medicine. Adv Immunol 54:1-10
2. An H, Ogata K, Kuriya S, Nomura T (1994) Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified mouse megakaryocytes. Exp Hematol 22:149-156
3. Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 75:1602-1607
4. Atkins MB, Kappler K, Mier JW, Isaacs RE, Berkman EM (1995) Interleukin-6-associated anemia: determination of the underlying mechanism. Blood 86:1288-1291
5. Bartley TD, Bogenberger J, Hunt P, et al (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117-1186
6. Bauer J, Herrmann F (1991) Interleukin-6 in clinical medicine. Ann Hematol 62:203-210
7. Biondi A, Rossi V, Bassan R, Barbui T, Bettoni S, Sironi M, Mantovani A, Rambaldi A (1989) Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 73:1279-1284
8. Brach MA, Herrmann F (1992) Interleukin-6: presence and future. Int J Clin Lab Res 22:143-151
9. Bruno E, Huffman R (1989) Effect of interleukin-6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines. Exp Hematol 17:1038-1043
10. Bruno E, Cooper RJ, Briddell RA, Hoffman R (1991) Further examination of the effects of recombinant cytokines on the proliferation of human megakaryocyte progenitor cells. Blood 77:2339-2346
11. Bruno E, Briddell RA, Cooper J, Hoffman R (1991) Effects of recombinant interleukin-11 on human megakaryocyte progenitor cells. Exp Hematol 19:378-381
12. Burstein SA, Harker LA (1989) Control of platelet production. Clin Haematol 12:3-22
13. Burstein SA, Downs T, Friese P, Lynam S, Anderson S, Henthorn J, Epstein RB, Savage K (1992) Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. Blood 80:420-428
14. Carrington PA, Hill RJ, Stenberg PE, Levin J, Corash L, Schreurs J, Baker G, Levin FC (1991) Multiple in vivo effects of interleukin-3 and interleukin-6 on murine megakaryocytopoiesis. Blood 77:34-41
15. Carrington PA, Hill RJ, Levin J, Verotta D (1992) Effects of interleukin 3 and interleukin 6 on platelet recovery in mice treated with 5-fluorouracil. Exp Hematol 20:462-467
16. Cox LH, Downs T, Dagg K, Henthorn J, Burstein SA (1991) Interleukin-6 mRNA and protein increase in vivo following induction of acute thrombocytopenia in mice. Blood 77:286-293
17. Cruickshand AM, Fraser WD, Burns HJG, van Damme J, Shenkin A (1990) Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 79:161-165
18. Debili N, Breton-Gorius J (1992) Hemopoietic growth factors and human megakaryocyte differentiation. Bone Marrow Transplant 9:11-15
19. de Sauvage FJ, Hass PE, Spencer SD, et al (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369:533-535
20. D'Hondt V, Weynants P, Humblet Y, Guillaume T, Canon JL, Beauduin M, Duprez P, Longueville J, Müll R, Chatelain C, Symann M (1993) Dose-dependent IL-3 stimulation of thrombopoiesis and neutropoiesis in patients with small cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase-Ib sludy. J Clin Oncol 11:2063-2072
21. D'Hondt V, Humblet Y, Guillaume T, Baatout S, Chatelain C, Berlière M. Longueville J, Feyens AM, De Greve J, Van Oosterom A, Von Graffenried B, Donnez J, Symann M (1995) Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicenter placebo-controlled, randomized phase-Ib study. Blood 85:2347-2353
22. Ertel W, Faist E, Nestle C, Hueltner L, Storck M, Schildberg FW (1990) Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res 48:622-628
23. Escary JL, Perreau J, Domenil D, Ezine S, Brulet P (1993) Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 63:361-364
24. Fong Y, Moldawer LL, Arano M, Wei H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF (1989) Endotoxemia elicits increased circulating beta 2-IFN/ IL-6 in man. J Immunol 142:2321-2324
25. Freeman GJ, Freedman AS, Rabinowe SN, Segil JM, Horowitz J, Rosen K, Whitman JF, Nadler LM (1989) Interleukin-6 gene expression in normal and neoplastic B cells. J Clin Invest 83:1512-1518
26. Geissler K, Valent P, Bettelheim P, Sillaber C, Wagner B, Kyrle P, Hinterberger W, Lechner K, Liehl E, Mayer P (1992) In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates. Blood 79:1155-1160
27. Gordon MS, Nemunaitis J, Hoffman R, Paquette RL, Rosenfeld C, Manfreda S, Isaacs R, Nimer SD (1995) A phase-I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood 11:3066-3076
28. Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM, Winchurch RA (1990) Increased levels of circulating interleukin-6 in burn patients. Clin Immunol Immunopathol 54:361-371
29. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW (1994) Thrombocytopenia in c-mpl-deficient mice. Science 265:1445-1447
30. Hack CE, De Groot ER, Felt-Bersma RJF, Nuijens JH, Strack van Schijndel RJMS, Eerenberg-Belmer AJ, Thijs LG, Aarden LA (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710
31. Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265:621-636
32. Helfgott DC, Tatter SB, Santhanam U, Clarick RH, Bhardwaj N, May LT, Sehgal PB (1989) Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142:948-953
33. Herodin F, Mestries J-C, Janodet D (1992) Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons. Blood 80:688-694
34. Hill RJ, Warren MK, Levin J (1990) Stimulation of thrombopoiesis in mice by human recombinant interleukin-6. J Clin Invest 85:1242-1247
35. Hill RJ, Warren MK, Stenberg P, Levin J, Corash L, Drummond R, Baker G, Levin F, Mok Y (1991) Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6. Blood 77:42-48
36. Hill RJ, Warren MK, Levin J, Gauldie J (1992) Evidence that interleukin-6 does not play a role in the stimulation of platelet production after induction of acute thrombocytopenia. Blood 80:346-351
37. Hoffman R (1989) Regulation of megakaryocytopoiesis. Blood 74:1196-1212
38. Hollen CW, Henthron J, Koziol JA, Burstein SA (1991) Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 79:286-290
39. Hollen CW, Henthron J, Koziol JA, Burstein SA (1992) Serum interleukin-6 levels in patients with thrombocytosis. Leukemia Lymphoma 8:235-241
40. Houssiau F, Devogelaer JP, van Damme J, De Deuxchaisnes CN, van Snick J (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31:784-788
41. Hovdenes J, Kvien TK, Hovdenes AB (1990) IL-6 in synovial fluids, plasma and supernatants from cultured cells of patients with rheumatoid arthritis and other inflammatory arthritides. Scand J Rheumatol 19:177-182
42. Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, Okumura N, Nakahata T (1991) Interleukin-6 supports human megakaryocytic proliferation and differentation in vitro. Blood 78:1969-1974
43. Ishibashi T, Kimura H, Shikama Y, et al (1989) Interleukin-6 is a potent thrombopoietic factor in vitro in mice. Blood 74:1241-1249
44. Ishibashi T, Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA (1989) Human interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86:5953-5957
45. Ishida Y, Yano S, Yoshida T, Tanaka H, Yamada Y, Kawano M, Kaneko T, Matsumoto N (1991) Biological effects of recombinant erythropoietin, granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-6 on purified rat megakaryocytes. Exp Hematol 19:608-612
46. Kanz L, Hollen CW, Friese P, Burstein SA (1990) Analysis of megakaryocyte ploidy in patients with thrombocytosis. Int J Cell Cloning 8:299-306
47. Kaushansky K, Lok S, Holly RD, et al (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369:568-571
48. Kishimoto T (1989) The biology of interleukin-6. Blood 74:1-10
49. Kishimoto T, Akira S, Taga T (1992) Interleukin-6 and its receptor: a paradigm for cytokines. Science 258:593-595
50. Kimura H, Ishibashi T, Shikama Y, Okano A, Akiyama Y, Uchida T, Maruyama Y (1990) Interleukin-1 beta (IL-1beta) induces thrombocytosis in mice: possible implication of IL-6. Blood 76:2493-2498
51. Kimura H, Ishibashi T, Uchida T, Maruyama Y, Friese P, Burstein SA (1990) Interleukin-6 is a differentiation factor for human megakaryocytes in vitro. Eur J Immunol 20:1927-1931
52. Kobayashi S, Teramura M, Sugawara I, Oshimi K, Mizoguchi H (1993) Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood 81:889-893
53. Lazarus HM, Winton EF, Williams SF, Grinblatt D, Campion M, Cooper BW, Gunn H, Manfreda S, Isaacs RE (1995) Phase-I multicenter trial of interleukin-6 therapy after autologous bone marrow transplantation in advanced breast cancer. Bone Marrow Transplant 15:935-942
54. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH, Scholmerich J (1991) Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatis. Gastroenterology 101:782-785
55. Leven RM, Rodriguez A (1991) Immunomagnetic bead isolation of megakaryocytes from guinea-pig bone marrow: effect of recombinant interleukin-6 on size, ploidy and cytoplasmic fragmentation. Br J Haematol 77:267-273
56. Lok S, Kaushansky K, Holly RD, et al (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565-568
57. McDonald TP, Cottrell MB, Swearington CJ, Clift RE (1991) Comparative effects of thrombopoietin and interleukin-6 on murine megakaryocytopoiesis and platelet production. Blood 77:735s
58. McIntosh JK, Jablons DM, Mule JJ, Nordan RP, Rudikoff S, Lotze MT, Rosenberg SA (1989) In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol 143:162-167
59. Mayer P, Geissler K, Valent P, Ceska M, Bettelheim P, Liehl E (1991) Recombinant human interleukin-6 is a potent inducer of the acute phase response and elevates the blood platelet in nonhuman primates. Exp Hematol 19:688-696
60. Mei RL, Burstein SA (1991) Megakaryocytic maturation in murine long-term bone marrow culture: role of interleukin-6. Blood 78:1438-1447
61. Metcalf D, Nicola NA, Gearing DP (1990) Effects of injected leukemia inhibitory factor in hematopoietic and other tissues in mice. Blood 76:50-56
62. Metcalf D, Hilton D, Nicola NA (1991) Leukemic inhibitory factor can potentiate murine megakaryocyte production in vitro. Blood 77:2150-2156
63. Murakami M, Hibi M, Nakagawa N, et al (1993) IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1805-1808
64. Nakayama K (1994) Detection of IL-6 and its receptor mRNAs in a megakaryocytic cell line, CMK, by an RT-nested PCR. Ann Hematol 69:245-247
65. Navarro S, Debili N, Le Couedic JP, Klein B, Breton-Gorius J, Doly J, Vainchenker W (1991) Interleukin-6 and its receptor are expressed by human megakaryocytes in vitro effects on proliferation and endoreplication. Blood 77:461-471
66. Nieken J, Mulder NH, Buter J, Vellenga E, Limburg PC, Piers DA, de Vries EGE (1995) Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood 86:900-905
67. Patchen ML, MacVittie TJ, Williams JL, Schwartz R, Souza LM (1991) Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 77:472-477
68. Patchen ML, Fischer R, MacVittie TJ (1993) Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia. Exp Hematol 21:338-344
69. Peng JP, Friese P, George JN, Dale GL, Burstein SA (1994) Alteration of platelet function in dogs mediated by interleukin-6. Blood 83:398-403
70. Pettengell R, Luft T, De Wynter E, Coutinho L, Young R, Fitzsimmons L, Howard Scarffe J, Testa NG (1995) Effects of interleukin-6 on mobilization of primitive haemopoietic cells into the circulation. Br J Haematol 89:237-242
71. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H. Ciliberto G, Rondan G, Constantini F (1994) Interleukin-6-deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196
72. Quesenberry PJ, McGrath HE, Williams ME, Robinson BE, Deacon DH, Clark S, Urdal D, McNiece IK (1991) Multifactor stimulation of megakaryocytopoiesis: effects of interleukin-6. Exp Hematol 19:35-41
73. Ryffel B, Car BD, Woerly G, Weber M, DiPadova F, Kammüller M, Klug S, Neubert R, Neubert D (1994) Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate-the marmoset. Blood 13:2093-2102
74. Schrezenmeier H, Marsh JC, Stromeyer P, Muller H, Heimpel H, Gordon-Smith EC, Raghavachar A (1995) A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia. Br J Haematol 90:283-292
75. Sehgal PB (1990) Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol Biol Med 7:117-130
76. Shenkin A, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJG, van Damme J (1989) The serum interleukin-6 response to selective surgery. Lymphokine Research 8:123-127
77. Sims RB, Gewirtz AM (1989) Human megakaryocytopoiesis. Annu Rev Med 40:213-224
78. Stahl CP, Zucker-Franklin D, Evatt BL, Winton EF (1991) Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates. Blood 78:1467-1475
79. Suda T, Yamaguchi Y, Suda J, Miura Y, Okano A, Akiyama Y (1988) Effect of interleukin 6 (IL-6) on the differentiation and proliferation of murine and human hemopoietic progenitors, Exp Hematol 16:891-895
80. Tabibzadedh SS, Poubouridis D, May LT, Sehgal PB (1989) Interleukin-6 immunoreactivity in human tumors. Am J Pathol 135:427-433
81. Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H (1992) Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 79:327-331
82. Utsumi K, Takai Y, Tada T, Fujiwara H, Hamoaka T (1990) Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production. J Immunol 145:397-403
83. Van Damme J, Schaafsma MR, Fibbe WE, Falkenburg JHF, Opdenakker G, Billiau A (1989) Simultaneous production of interleukin-6, interferon-beta and colony-stimulating activity by fibroblasts after viral and bacterial infection. Eur J Immunol 19:163-168
84. van Gameren MM, Willemse PHB, Mulder NH, Limburg PC, Groen HJM, Vellenga E, de Vries EGE (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 84:1434-1441
85. Veldhuis GJ, Willemse PHB, Sleijfer DT, van der Graaf WTA, Groen HJM, Limburg PC, Mulder NH, de Vries EGE (1995) Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer. J Clin Oncol 13:2585-2593
86. Warren MK, Conroy LB, Rose JS (1989) The role of interleukin-6 and interleukin-1 in megakaryocyte development. Exp Hematol 17:1095-1099
87. Weber J, Yang J, Topalian S, Parkinson D, Schwartzentruber D, Ettinghausen S, Gunn H, Mixon A, Kim H, Levin R, Rosenberg S (1993) Phase-I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 11:499-506
88. Wendung F, Maraskovsky E, Debili N, et al (1994) c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571-574
89. Winton E, Srinivasiah J, Kim BK, Hillyer C, Strobert EA, Orkin JL, Swenson RB, McClure HM, Myers LA, Saral R (1994) Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model. Blood 84:65-73
90. Zeidler C, Kanz L, Hurkuck, Rittmann KL, Widfang I, Kadoya T, Mikayama T, Souza L, Welte K (1992) In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates. Blood 80:2740-2745